Advertisement
top banner image  

topleft corner image     top right corner image
 
take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc imaging image
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

JACC Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

     top nav image

     

J Am Coll Cardiol Img, 2009; 2:869-879, doi:10.1016/j.jcmg.2009.04.008
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Appendix
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujii, H.
Right arrow Articles by Li, R.-K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fujii, H.
Right arrow Articles by Li, R.-K.
Related Collections
Right arrowRelated Article

Ultrasound-Targeted Gene Delivery Induces Angiogenesis After a Myocardial Infarction in Mice

Hiroko Fujii, MD, PhD*, Zhuo Sun, MD*, Shu-Hong Li, MD, MSc*, Jun Wu, MD*, Shafie Fazel, MD, PhD*, Richard D. Weisel, MD*, Harry Rakowski, MD{dagger}, Jonathan Lindner, MD{ddagger}, Ren-Ke Li, MD, PhD*,*

* Division of Cardiovascular Surgery, Toronto General Research Institute and Toronto General Hospital, Toronto, Ontario, Canada
{dagger} Division of Cardiology, Toronto General Research Institute and Toronto General Hospital, Toronto, Ontario, Canada
{ddagger} Cardiovascular Division, Oregon Health and Science University, Portland, Oregon

* Reprint requests and correspondence: Dr. Ren-Ke Li, Toronto General Research Institute, MaRS Centre, Toronto Medical Discovery Tower, Room 3-702, 101 College Street, Toronto, Ontario, Canada M5G 1L7 (Email: renkeli{at}uhnres.utoronto.ca).

Objectives: This study evaluated the capacity of ultrasound-targeted microbubble destruction (UTMD) to deliver angiogenic genes, improve perfusion, and recruit progenitor cells after a myocardial infarction (MI) in mice.

Background: Angiogenic gene therapy after an MI may become a clinically relevant approach to improve the engraftment of implanted cells if targeted delivery can be accomplished noninvasively. The UTMD technique uses myocardial contrast echocardiography to target plasmid gene delivery to the myocardium and features low toxicity, limited immunogenicity, and the potential for repeated application.

Methods: Empty plasmids (control group) or those containing genes for vascular endothelial growth factor (VEGF), stem cell factor (SCF), or green fluorescent protein (to visualize gene delivery) were incubated with perflutren lipid microbubbles. The microbubble-deoxyribonucleic acid mixture was injected intravenously into C57BL/6 mice at 7 days after coronary artery ligation (MI). The UTMD technique facilitated transgene release into the myocardium. Twenty-one days after MI, myocardial perfusion and function were assessed by contrast echocardiography. Protein expression was quantified by Western blot and enzyme-linked immunosorbent assay. Flow cytometry quantified progenitor cell recruitment to the heart. Blood vessel density was evaluated immunohistochemically.

Results: Green fluorescent protein expression in the infarcted myocardium demonstrated gene delivery. Myocardial VEGF and SCF levels increased significantly in the respective groups (p < 0.05). The physiologic impact of VEGF and SCF gene delivery was confirmed by increased myocardial recruitment of VEGF receptor 2– and SCF receptor (c-kit)–expressing cells, respectively (p < 0.05). Consequently, capillary and arteriolar density (Factor VIII and alpha-smooth muscle actin staining), myocardial perfusion, and cardiac function were all enhanced (p < 0.01 relative to control group) in recipients of VEGF or SCF.

Conclusions: Noninvasive UTMD successfully delivered VEGF and SCF genes into the infarcted heart, increased vascular density, and improved myocardial perfusion and ventricular function. The UTMD technique may be an ideal method for noninvasive, repeated gene delivery after an MI.

Key Words: angiogenesis • echocardiography • gene therapy • microbubbles • myocardial infarction

Abbreviations and Acronyms
  EF = ejection fraction
  FAC = fractional area change
  GFP = green fluorescent protein
  LV = left ventricle
  LVEAd = left ventricular end-diastolic area
  LVEAs = left ventricular end-systolic area
  LVEDV = left ventricular end-diastolic volume
  LVESV = left ventricular end-systolic volume
  MCE = myocardial contrast echocardiography
  MI = myocardial infarction
  PBS = phosphate-buffered saline
  SCF = stem cell factor
  SMA = smooth muscle actin
  UTMD = ultrasound-targeted microbubble destruction
  VEGF = vascular endothelial growth factor


Related Article

Ultrasound Mediated Destruction of DNA-Loaded Microbubbles for Enhancement of Cell-Based Therapies: New Promise Amidst a Confluence of Uncertainties?
Flordeliza S. Villanueva
J. Am. Coll. Cardiol. Img. 2009 2: 880-882. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll Cardiol ImgHome page
F. S. Villanueva
Ultrasound Mediated Destruction of DNA-Loaded Microbubbles for Enhancement of Cell-Based Therapies: New Promise Amidst a Confluence of Uncertainties?
J. Am. Coll. Cardiol. Img., July 1, 2009; 2(7): 880 - 882.
[Full Text] [PDF]



Advertisement
 
   
 
home link current link search link archive link topics link cardiology careers link